Fidelity Investments
IMNM icon

Fidelity Investments’s Immunome IMNM Stock Holding History

Fidelity Investments’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$360M Buy
16,987,553
+17,599
+0.1% +$377K 0.02% 679
2026
Q1 		$371M Buy
16,969,954
+420,238
+3% +$9.35M 0.02% 624
2025
Q4 		$355M Buy
16,549,716
+3,493,007
+27% +$61.3M 0.02% 634
2025
Q3 		$153M Buy
13,056,709
+6,889,043
+112% +$68.5M 0.01% 969
2025
Q2 		$57.4M Buy
6,167,666
+2,275,348
+58% +$18.7M ﹤0.01% 1343
2025
Q1 		$26.2M Sell
3,892,318
-26,898
-0.7% -$258K ﹤0.01% 1591
2024
Q4 		$41.6M Sell
3,919,216
-305,484
-7% -$3.69M ﹤0.01% 1448
2024
Q3 		$61.8M Buy
4,224,700
+13,757
+0.3% +$195K ﹤0.01% 1288
2024
Q2 		$51M Sell
4,210,943
-323,700
-7% -$5.06M ﹤0.01% 1309
2024
Q1 		$112M Buy
4,534,643
+628,500
+16% +$12.8M 0.01% 1011
2023
Q4 		$41.8M Buy
+3,906,143
New +$32.5M ﹤0.01% 1358
2021
Q4 		– Sell
-32
Closed -$1K – 4655
2021
Q3 		$1K Sell
32
-226,424
-100% -$3.95M ﹤0.01% 4151
2021
Q2 		$3.92M Hold
226,456
– – ﹤0.01% 2401
2021
Q1 		$7.67M Sell
226,456
-113,900
-33% -$2.83M ﹤0.01% 2135
2020
Q4 		$3.29M Buy
+340,356
New +$3.97M ﹤0.01% 2290

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments's IMNM Position: Q2 2026 in Review

Fidelity Investments increased its Immunome (IMNM) stake by 0.1% in Q2 2026, buying an estimated $377K and bringing the position to 16,987,553 shares worth $360M. The position accounts for 0.02% of the portfolio, ranked #679.

Fidelity Investments first reported a position in IMNM in Q4 2020 and has held it in 15 quarters since. The position peaked at $371M in Q1 2026. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Fidelity Investments held 16,987,553 shares of Immunome worth $360M as of Q2 2026.
  • Fidelity Investments bought 17,599 Immunome shares in Q2 2026, an estimated $377K.
  • Immunome made up 0.02% of Fidelity Investments's portfolio in Q2 2026, its #679 holding.
  • Fidelity Investments first reported a position in Immunome in Q4 2020 and has held it in 15 quarters since.
  • Fidelity Investments's Immunome position peaked at $371M in Q1 2026.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.